An Open-label, Randomized, Single-dose, 2X3X3 Partial Replicate, Crossover Study to Compare the Pharmacokinetics and Safety Between a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin and Co-administration of a Fixed Dose Combination of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Amlodipine/fimasartan/rosuvastatin (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 09 Aug 2017 Status changed from active, no longer recruiting to completed.
- 09 Aug 2017 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
- 20 Dec 2016 New trial record